Background: Brucelosis is a severe acute febrile disease caused by bacteria of the genus Brucella. Its current diagnosis is based on clinical observations that may be complemented by serology and microbiological culture tests; however, the former is limited in sensitivity and specificity, the latter is time consuming. To improve brucelosis diagnosis we developed a test which is specific and sensitive and is capable of differentiating the six species of Brucella. Materials and Methods: Four primers were designed from B. abortus sequences at the well-conserved Omp2 locus that are able to amplify the DNAs of all six species
INTRODUCTION
Brucelosis, a zoonosis of worldwide public health and economic importance, affects mainly domestic animals (cattle, sheep, goat, and swine), and it may be transmitted to humans by contact or consumption of contaminated dairy and meat products. The disease is caused by organisms of the genus Brucella, in which six closely related species have been distinguished on the basis of biochemical, physiological, and host-specificity differentiation resulted directly from differences in the amplification patterns or was achieved indirectly using a RFLP present in one of the PCR products. The sensitivity and specificity of the new test were then determined; it was applied successfully in confirming the diagnosis of a patient whose clinical history and serology indicated infection with Brucella. Conclusions: The results make possible the use of a PCR test for Brucella detection and differentiation without relying on the measurement of the antibodies or microorganism culture. Our first results showed that the PCR test can confirm the presence of Brucella in blood samples of infected patients. differences (1) . However, on the basis of their high DNA sequence similarity (>90%), some authors (2) have proposed B. melitensis as the only species.
In humans, the signs and symptoms for brucelosis can (3) (4) (5) or focus on the differentiation of the principal species affecting specific geographic regions (6) . Nevertheless, the ability to differentiate the six Brucella species will be useful to carry out epidemic studies of brucelosis incidence or to investigate the disease's aggressiveness. In our laboratory, the successful detection of B. abortus genomic sequences was achieved by PCR on DNA from infected bovine blood cells (7), using a set of primers derived from the sequence of two homologous genes (Omp2a and Omp2b) coding for a major outer membrane protein (porin) of these bacteria (8) Figure 1 . The primers sequences were 2ab5': 5'actg acggatccgcgctcaggcggccgacgcaa3', 2a900: 5' actg acttcgaattgccttttcgggggcaatga 3', 2ab200: 5' actg acttcgaaaccagccattgcggtcggtac, and 2b600: 5' act gaagcttagccgtcgatgtggtagt 3'.
Approximately 50 ng of DNA from each bacteria preparation was amplified in a total volume of 50 ,ul, using 2. (10) . Individual colonies were treated to isolate their plasmid DNA, which were screened by restriction enzyme analysis (10) and nucleotide sequencing of their inserts, using the dideoxy chain termination-DNA sequencing method (11) . After electrophoresis, the sequencing gel was dried and exposed on Kodak X-ray film at -70°C.
RESULTS

Detection and Differentiation of the Six Brucella Species
We examined whether our set of four PCR primers could be useful to amplify the DNAs tomae, were still indistinguishable using only their amplification pattern. Furthermore, sequencing of the 200-bp fragments obtained after DNA amplification of each species corroborated that the PCR products were indeed generated from the Omp2 region (data not shown) and demonstrated the specificity of our primers. On the basis of the restriction analysis reported by Ficht (9), we were able to predict that the PCR patterns would depend on the species but not on the biovariety. This reasoning was corroborated by the results obtained with biotypes 2 and 5 of B. melitensis and B. abortus, respectively, in which the amplification pattern was type I, as expected (data not shown).
To distinguish within the three species giving pattern I, an enzymatic characterization of the 900-bp fragment was carried out; only KpnI restriction enzyme allowed us to find differences. The KpnI restriction site was present in B. melitensis (Bv. 1) 900-bp PCR fragment, but absent in B. suis. Interestingly, in B. neotomae we found both patterns-an intact band of 900 bp coming from the amplification of Omp2a and two additional fragments of approximately 700 and 200 bp from KpnI digestion of the Omp2b PCR product (Fig. 3) .
Detection Limit and Specificity of the PCR Method In the first attempts to establish our PCR method we used 50 ng of DNA. To test the detection limit, decreasing amounts of DNA were assayed. We found that 1 ng of DNA was enough to detect and differentiate all Brucella species; but for B. suis, 10 ng of DNA was needed (Fig. 4) . In addition, to test the specificity of our assay, we used our method with DNA from other bacteria; porins have been reported for some of these (12) . None of the bacteria resulted positive with our PCR method (Table 1) . When the same reaction mix was challenged with DNA from B. abortus as positive control for these assays, we obtained the expected amplification pattern, confirming that the reactions were devoid of PCR inhibitors (data not shown).
Detection of Brucella in Blood Samples
Genomic DNA was extracted from a blood sample of a pediatric patient who presented clinical symptomology of Brucella infection and positive serology, and then it was amplified using the four-primer PCR assay. As shown in Figure 5 , no amplification was observed with the DNA control extracted from a healthy control subject. In the patient, we obtained the pattern (type I) corresponding to the undifferentiated species. KpnI digestion of the amplified product revealed that the likely species involved was B. melitensis. After medical treatment of this patient, we again isolated the DNA from a sample of his blood and performed the PCR assay. The result of this new amplification was only the band of 200 bp (data not shown). This result may be explained by the reduction of the bacteria in the blood of the patient, since, as shown in Figure 4 , the decrease in DNA to 0.1 ng in the PCR reaction produced only the amplification product of 200 An important aspect of a diagnostic test is its specificity. PCR specificity depends both on the gene selected for amplification and on the primers' uniqueness. Although, the primers were designed from the Omp2 locus, no microorganisms different from Brucella cross-reacted. This result was consistent, regardless of whether they contained porin genes (12) .
An annealing temperature of 66°C was used to increase specificity. However, as the primers were designed to match sequences at the Omp2 locus of B. abortus, under this more stringent condition the sensitivity of the test was lower when trying to detect the other species of Brucella. This is probably because these other species' target sites in the Omp2 locus do not match perfectly to the primers. Further adjustments to the assay through species-specific primers should increase PCR sensitivity. The development of the assay was accomplished by using purified DNA from Brucella strains, but as a further step we applied it to clinical samples to verify the feasibility of using it for Brucella diagnosis in humans. Although the application of our PCR assay in diagnosis is preliminary (only one patient was tested), it presents several advantages over the current techniques used for Brucella diagnosis and serotyping. Perhaps the most important advantage is the shortened time needed to perform a diagnosis (less than a single day versus the several weeks needed to isolate and culture the Brucella organism). It is clear that PCR will be an important tool in the diagnosis of Brucella because of its sensitivity and specificity. Experiments on the optimization and validation of our PCR method in a larger sampling of patients are currently underway.
